MAPT and Alzheimer disease: Tau protein, the main component of neurofibrillary tangles (NFTs) (16), one of the two molecular hallmarks of AD with amyloid plaques, is subjected to O-GlcNAc modification which was initially estimated to 4 O-GlcNAc group per tau molecule on at least 12 Ser/Thr sites (17).